TPTE2

gene
On this page

Also known as TPIP

Summary

TPTE2 (transmembrane phosphoinositide 3-phosphatase and tensin homolog 2, HGNC:17299) is a protein-coding gene on chromosome 13q12.11, encoding Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (Q6XPS3). Acts as a lipid phosphatase, removing the phosphate in the D3 position of the inositol ring from phosphatidylinositol 3,4,5-trisphosphate.

TPIP is a member of a large class of membrane-associated phosphatases with substrate specificity for the 3-position phosphate of inositol phospholipids.

Source: NCBI Gene 93492 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 104 total
  • MANE Select transcript: NM_001395978

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:17299
Approved symbolTPTE2
Nametransmembrane phosphoinositide 3-phosphatase and tensin homolog 2
Location13q12.11
Locus typegene with protein product
StatusApproved
AliasesTPIP
Ensembl geneENSG00000132958
Ensembl biotypeprotein_coding
OMIM606791
Entrez93492

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 9 protein_coding, 2 nonsense_mediated_decay

ENST00000382978, ENST00000390680, ENST00000400103, ENST00000462409, ENST00000696857, ENST00000696858, ENST00000696859, ENST00000696860, ENST00000696861, ENST00000696988, ENST00000697147

RefSeq mRNA: 4 — MANE Select: NM_001395978 NM_001141968, NM_001395978, NM_130785, NM_199254

CCDS: CCDS45013, CCDS45014, CCDS9285

Canonical transcript exons

ENST00000697147 — 23 exons

ExonStartEnd
ENSE000014941341942287719423164
ENSE000016795341942642519426517
ENSE000016894281947557319475623
ENSE000017105461945026319450344
ENSE000017892311945007619450164
ENSE000039686511949344819493501
ENSE000039686531948248819482547
ENSE000039686551955257119552673
ENSE000039686561950322419503277
ENSE000039686611955902819559129
ENSE000039686621943046819430547
ENSE000039686631947391419474075
ENSE000039686641946722519467344
ENSE000039686681942494719425017
ENSE000039686701949285019492903
ENSE000039686721943247319432578
ENSE000039686741943622619436306
ENSE000039686751946525519465318
ENSE000039686761945116519451225
ENSE000039686771946445619464520
ENSE000039686781956143419561532
ENSE000039686791943809219438153
ENSE000039686801946546519465564

Expression profiles

Bgee: expression breadth ubiquitous, 123 present calls, max score 83.17.

Top tissues by expression

129 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047383.17gold quality
right testisUBERON:000453479.62gold quality
left testisUBERON:000453379.05gold quality
testisUBERON:000047378.84gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099176.80gold quality
sural nerveUBERON:001548862.98silver quality
prefrontal cortexUBERON:000045159.91gold quality
bone marrow cellCL:000209259.70silver quality
frontal cortexUBERON:000187057.80gold quality
Brodmann (1909) area 9UBERON:001354057.67gold quality
dorsolateral prefrontal cortexUBERON:000983457.42gold quality
cerebellar hemisphereUBERON:000224557.23gold quality
cerebellar cortexUBERON:000212957.21gold quality
cerebellumUBERON:000203756.96gold quality
superior frontal gyrusUBERON:000266156.63gold quality
mucosa of stomachUBERON:000119956.34gold quality
putamenUBERON:000187456.18gold quality
ventricular zoneUBERON:000305356.17gold quality
cerebral cortexUBERON:000095656.14gold quality
anterior cingulate cortexUBERON:000983555.96gold quality
right hemisphere of cerebellumUBERON:001489055.75gold quality
right frontal lobeUBERON:000281055.27gold quality
duodenumUBERON:000211454.79gold quality
lymph nodeUBERON:000002953.94gold quality
brainUBERON:000095553.52gold quality
primary visual cortexUBERON:000243653.38gold quality
mucosa of transverse colonUBERON:000499152.85gold quality
hypothalamusUBERON:000189852.78gold quality
caudate nucleusUBERON:000187352.74gold quality
right adrenal gland cortexUBERON:003582752.46gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes5.65

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

20 targeting TPTE2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-318599.9968.121959
HSA-MIR-119799.7067.751027
HSA-MIR-7-5P99.6770.531809
HSA-MIR-1207-5P99.4969.112983
HSA-MIR-6722-3P99.4567.621919
HSA-MIR-410-3P99.2769.982457
HSA-MIR-10522-5P99.2668.502087
HSA-MIR-397899.2468.392201
HSA-MIR-4763-3P99.1067.832649
HSA-MIR-1909-3P99.0366.561662
HSA-MIR-4711-5P98.8968.00965
HSA-MIR-317998.2265.901445
HSA-MIR-939-5P97.1065.801579
HSA-MIR-1343-5P96.4866.061506
HSA-MIR-6726-5P95.9763.72841
HSA-MIR-430095.8564.561003
HSA-MIR-5591-5P95.8564.761002
HSA-MIR-127-3P93.9266.4236

Literature-anchored findings (GeneRIF, showing 4)

  • the TPIP splice-variant (TPIP-C2) mRNA is expressed in human and mouse tissues and strongly inhibits cell growth in HeLa cells (PMID:22164291)
  • findings suggest that C2-domain of TPIP-C2 may act as a dominant negative effector, which may bind to and arrest the cell proliferation signalling complex (PMID:22311048)
  • TPTE2 was originally reported to be a phosphoinositide 3’-phosphatase, like the tumor suppressor PTEN. Later on, other homologous phosphatases, such as Ci-VSP and Dr-VSP, have been described. These proteins are 5’-phosphatases. More recently, using a chimeric construct, we have shown that the catalytic domain of TPTE2 behaves as a 5’-phosphatase as well. (PMID:22896666)
  • The role of TPTE2 in gallbladder cancer cells (PMID:25676706)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriotpteENSDARG00000056985
mus_musculusTpteENSMUSG00000031481
rattus_norvegicusTpte2ENSRNOG00000024837

Paralogs (6): TNS1 (ENSG00000079308), HVCN1 (ENSG00000122986), TNS3 (ENSG00000136205), TMEM266 (ENSG00000169758), PTEN (ENSG00000171862), TPTE (ENSG00000274391)

Protein

Protein identifiers

Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2Q6XPS3 (reviewed: Q6XPS3)

Alternative names: Lipid phosphatase TPIP, TPTE and PTEN homologous inositol lipid phosphatase

All UniProt accessions (6): A0A8Q3SIW4, Q6XPS3, A0A8Q3SJ09, A0A8Q3SJ26, A0A8Q3SJ67, G3V171

UniProt curated annotations — full annotation on UniProt →

Function. Acts as a lipid phosphatase, removing the phosphate in the D3 position of the inositol ring from phosphatidylinositol 3,4,5-trisphosphate. Shows no phosphoinositide phosphatase activity.

Subcellular location. Endoplasmic reticulum membrane Endoplasmic reticulum membrane. Golgi apparatus membrane Cytoplasm.

Tissue specificity. Isoform 3 is expressed in testis, brain and stomach while isoform 4 seems to be testis-specific.

Miscellaneous. Expressed in testis, strongly inhibits cell growth in HeLa cells.

Isoforms (7)

UniProt IDNamesCanonical?
Q6XPS3-11, TPIP gammayes
Q6XPS3-22
Q6XPS3-33, TPIP alpha
Q6XPS3-44, TPIP beta
Q6XPS3-55
Q6XPS3-66, TPIP-C2
Q6XPS3-77

RefSeq proteins (4): NP_001135440, NP_001382907, NP_570141, NP_954863 (=MANE)

Domains & families (InterPro)

IDNameType
IPR000387Tyr_Pase_domDomain
IPR005821Ion_trans_domDomain
IPR014020Tensin_C2-domDomain
IPR016130Tyr_Pase_ASActive_site
IPR027359Volt_channel_dom_sfHomologous_superfamily
IPR029021Prot-tyrosine_phosphatase-likeHomologous_superfamily
IPR029023Tensin_phosphataseDomain
IPR035892C2_domain_sfHomologous_superfamily
IPR045102PTP_VSP_TPTEDomain
IPR051281Dual-spec_lipid-protein_phosphFamily
IPR057023PTP-SAKDomain

Pfam: PF00520, PF10409, PF22784

Catalyzed reactions (Rhea), 1 shown:

  • a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate) + H2O = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate) + phosphate (RHEA:25017)

UniProt features (21 total): splice variant 7, transmembrane region 3, sequence variant 2, domain 2, compositionally biased region 2, chain 1, mutagenesis site 1, sequence conflict 1, region of interest 1, active site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6XPS3-F185.000.58

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (1): 320 (phosphocysteine intermediate)

Mutagenesis-validated functional residues (1):

PositionPhenotype
320loss of activity.

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-1660514Synthesis of PIPs at the Golgi membrane

MSigDB gene sets: 48 (showing top): GOBP_PHOSPHOLIPID_METABOLIC_PROCESS, GOBP_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS, MODULE_493, GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS, GOBP_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS, GOBP_GLYCEROLIPID_METABOLIC_PROCESS, MODULE_285, MODULE_171, GOBP_GLYCEROLIPID_BIOSYNTHETIC_PROCESS, GOBP_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_LIPID_BIOSYNTHETIC_PROCESS, GOBP_TRANSMEMBRANE_TRANSPORT, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN

GO Biological Process (8): phosphatidylinositol biosynthetic process (GO:0006661), lipid metabolic process (GO:0006629), phosphate-containing compound metabolic process (GO:0006796), monoatomic ion transport (GO:0006811), dephosphorylation (GO:0016311), monoatomic ion transmembrane transport (GO:0034220), transmembrane transport (GO:0055085), proton transmembrane transport (GO:1902600)

GO Molecular Function (6): monoatomic ion channel activity (GO:0005216), phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity (GO:0016314), phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity (GO:0051800), hydrolase activity (GO:0016787), phosphatase activity (GO:0016791), voltage-gated proton channel activity (GO:0030171)

GO Cellular Component (9): Golgi membrane (GO:0000139), cytoplasm (GO:0005737), endoplasmic reticulum membrane (GO:0005789), cytosol (GO:0005829), endoplasmic reticulum (GO:0005783), Golgi apparatus (GO:0005794), plasma membrane (GO:0005886), membrane (GO:0016020), monoatomic ion channel complex (GO:0034702)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
PI Metabolism1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
cytoplasm3
transport2
endomembrane system2
intracellular membrane-bounded organelle2
biosynthetic process1
phosphatidylinositol metabolic process1
primary metabolic process1
metabolic process1
phosphate-containing compound metabolic process1
monoatomic ion transport1
transmembrane transport1
cellular process1
monoatomic cation transmembrane transport1
monoatomic ion transmembrane transporter activity1
channel activity1
phosphatidylinositol trisphosphate phosphatase activity1
phosphatidylinositol-3,4-bisphosphate phosphatase activity1
catalytic activity1
phosphoric ester hydrolase activity1
proton channel activity1
voltage-gated monoatomic cation channel activity1
Golgi apparatus1
bounding membrane of organelle1
intracellular anatomical structure1
organelle membrane1
nuclear outer membrane-endoplasmic reticulum membrane network1
endoplasmic reticulum subcompartment1
membrane1
cell periphery1
transmembrane transporter complex1

Protein interactions and networks

STRING

1635 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TPTE2MTMR2Q13614861
TPTE2TMEM266Q2M3C6489
TPTE2HAUS6Q7Z4H7470
TPTE2GUCY1A2P33402469
TPTE2PTENP60484441
TPTE2NUDT21O43809433
TPTE2NDUFS6O75380432
TPTE2PGAM2P15259417
TPTE2MTMR7Q9Y216410
TPTE2MTMR6Q9Y217404
TPTE2SDHAP31040389
TPTE2OR10S1Q8NGN2368
TPTE2MTMR14Q8NCE2348
TPTE2ZNF530Q6P9A1348
TPTE2INPP5BP32019342

IntAct

10 interactions, top by confidence:

ABTypeScore
TPTE2TLN1psi-mi:“MI:0407”(direct interaction)0.440
TPTE2CALD1psi-mi:“MI:0915”(physical association)0.400
TPTE2LMTK2psi-mi:“MI:0915”(physical association)0.370
TPTE2AATKpsi-mi:“MI:0915”(physical association)0.370
TPTE2PTK7psi-mi:“MI:0915”(physical association)0.370
TPTE2EPHA2psi-mi:“MI:0915”(physical association)0.370
Ppsi-mi:“MI:0914”(association)0.350
TPTE2DNAJB5psi-mi:“MI:0914”(association)0.350
TPTE2ARRB2psi-mi:“MI:0914”(association)0.350

BioGRID (112): HAUS1 (Affinity Capture-MS), OTUD4 (Affinity Capture-MS), PEX19 (Affinity Capture-MS), PPP2R3A (Proximity Label-MS), CCDC14 (Proximity Label-MS), CEP290 (Proximity Label-MS), NCKAP5L (Proximity Label-MS), AKAP9 (Proximity Label-MS), KIAA0753 (Proximity Label-MS), PIBF1 (Proximity Label-MS), CCDC77 (Proximity Label-MS), CCDC18 (Proximity Label-MS), CCDC61 (Proximity Label-MS), SSFA2 (Proximity Label-MS), CEP72 (Proximity Label-MS)

ESM2 similar proteins: A0A0G2JXT6, A0JMF6, A0JMK5, A2ALK8, A2BGG1, A6QLT4, A7MB43, G5ED68, O13819, O14830, P26045, P33402, P51432, Q09M05, Q13496, Q13613, Q15111, Q3USB7, Q4KWH5, Q4R6N0, Q4U2V3, Q52KU6, Q5EB32, Q5F452, Q5R6F6, Q5R9S3, Q5U581, Q62688, Q6AXQ4, Q6NU08, Q6TEL0, Q6XPS3, Q7TPM9, Q7ZXF1, Q8K394, Q8NCE2, Q8VE11, Q8VEL2, Q96EF0, Q96MI9

Diamond homologs: E9Q0S6, G5EE01, O08586, O54857, O94526, P56180, P60483, P60484, Q04205, Q4R6N0, Q54JL7, Q5B323, Q5SSZ5, Q68CZ2, Q6XPS3, Q86IL4, Q8H106, Q8T9S7, Q99KY4, Q9FLZ5, Q9GLM4, Q9HBL0, Q9LT75, Q9P7H1, Q9PUT6, A0AUV4, A8WYE4, B0WAU8, D2I3C6, D3ZBE5, F1LP90, F1MH24, F1SPM8, G5ECQ3, O13773, O14976, O34507, O43066, O75061, O75716

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

104 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance74
Likely benign7
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

2875 predictions. Top by Δscore:

VariantEffectΔscore
13:19425018:C:CCacceptor_gain1.0000
13:19450165:C:CCacceptor_gain1.0000
13:19451163:A:ACdonor_gain1.0000
13:19451164:C:CTdonor_gain1.0000
13:19451164:CTG:Cdonor_gain1.0000
13:19465317:AC:Aacceptor_gain1.0000
13:19465318:CC:Cacceptor_gain1.0000
13:19482558:C:CTacceptor_gain1.0000
13:19425016:TT:Tacceptor_gain0.9900
13:19438150:CTTC:Cacceptor_gain0.9900
13:19438154:C:CCacceptor_gain0.9900
13:19438154:CTA:Cacceptor_loss0.9900
13:19438155:T:Cacceptor_loss0.9900
13:19450161:CTCA:Cacceptor_gain0.9900
13:19450163:CA:Cacceptor_gain0.9900
13:19451160:CATA:Cdonor_gain0.9900
13:19451222:CTTC:Cacceptor_gain0.9900
13:19464517:CGTT:Cacceptor_gain0.9900
13:19465250:CAAA:Cdonor_loss0.9900
13:19465251:AAACC:Adonor_loss0.9900
13:19465252:AAC:Adonor_loss0.9900
13:19465253:A:Gdonor_loss0.9900
13:19465254:C:CGdonor_loss0.9900
13:19465319:C:Tacceptor_gain0.9900
13:19473912:AC:Adonor_gain0.9900
13:19473913:CC:Cdonor_gain0.9900
13:19473913:CCCTT:Cdonor_gain0.9900
13:19482559:A:Tacceptor_gain0.9900
13:19492904:C:CCacceptor_gain0.9900
13:19493443:CTTA:Cdonor_loss0.9900

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000008667 (13:19468361 G>C), RS1000017231 (13:19558265 C>A,T), RS1000081267 (13:19424464 T>A,C), RS1000115151 (13:19538013 A>T), RS1000124539 (13:19519811 A>G), RS1000125070 (13:19504916 T>C), RS1000155530 (13:19519492 G>T), RS1000209057 (13:19523803 G>A), RS1000232115 (13:19524216 A>G), RS1000234488 (13:19467904 T>C,G), RS1000269193 (13:19511397 A>G), RS1000353241 (13:19497734 G>C,T), RS1000371772 (13:19430104 G>A), RS1000388654 (13:19526676 T>C), RS1000458000 (13:19517579 A>C)

Disease associations

OMIM: gene MIM:606791 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST010678_5Liver fibrosis (total hepatic collagen content)8.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0010576liver fibrosis measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

11 total (human), top 11 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aincreases methylation1
nickel sulfateincreases expression1
tanespimycinincreases expression1
scriptaidaffects expression1
Hydralazineaffects cotreatment, increases expression1
Methotrexateincreases expression1
Silicon Dioxidedecreases expression1
Valproic Acidaffects cotreatment, increases expression1
Aflatoxin B1decreases expression1
Permethrindecreases expression1
Nanotubes, Carbonincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.